Web-Based Intervention for Cancer Pain in Breast Cancer Survivors
(CAI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a web-based app designed to help breast cancer survivors manage cancer pain and related depressive symptoms. Participants will use either an individualized coaching program or a standard information program, both delivered through the app. The goal is to determine if the personalized approach improves pain and mood more effectively than the standard method. Women who are Chinese, Korean, or Japanese, have been diagnosed with breast cancer in the past, and are currently experiencing cancer pain and depressive symptoms might be suitable candidates. Participants need internet access and should not be undergoing active depression treatment.
As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance the quality of life for breast cancer survivors.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are in active depression treatment, you will be excluded from the R33 phase of the study.
What prior data suggests that this web-based intervention is safe for breast cancer survivors?
Research shows that the online programs CAI and CAPA help manage cancer pain. These programs deliver information and support through an app. Early studies found that most users handle these apps well, with no major reports of negative effects. While testing and improvements continue, the goal remains to manage pain without adding new risks. This suggests they are safe for managing cancer pain, although individual results may vary.12345
Why are researchers excited about this trial?
Researchers are excited about these treatments for cancer pain in breast cancer survivors because they leverage web-based apps to provide personalized coaching and support, offering a novel approach to pain management. Unlike traditional pain therapies that often rely on medications like opioids, these apps focus on individualized coaching, allowing for optimization based on each user's specific needs. This digital delivery method not only broadens accessibility but also empowers patients to manage their pain actively, potentially leading to better outcomes and improved quality of life.
What evidence suggests that this trial's treatments could be effective for cancer pain in breast cancer survivors?
Research has shown that online programs like CAI and CAPA, both studied in this trial, hold promise for managing cancer pain. Early results suggest these programs help by providing personalized information and support, improving pain management and related issues like depression. In this trial, participants in the CAI arm will receive one-on-one coaching tailored to individual needs, potentially increasing effectiveness compared to standard methods. Studies have found these programs to be culturally tailored, enhancing relevance and impact for specific groups, such as Asian American breast cancer survivors. These programs aim to boost users' confidence and belief in their ability to manage cancer pain effectively.12346
Who Is on the Research Team?
Eun Ok Im
Principal Investigator
The University of Texas at Austin
Are You a Good Fit for This Trial?
This trial is for women over 18 who identify as Chinese, Korean, or Japanese; can read and write English or their native languages; have internet access; experienced cancer pain in the past week and depressive symptoms in the last two weeks. They must also have been diagnosed with breast cancer within the last five years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
R61 Phase - Intervention Development
Development and evaluation of CAI through expert review and usability test
R33 Phase - Randomized Control Trial
Randomized repeated measures control group design to test CAI efficacy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CAI
- CAPA
CAI is already approved in United States for the following indications:
- Cancer pain management
- Depressive symptoms accompanying pain in Asian American breast cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor